Published: May 6th 2020 | Updated: September 16th 2024
Gastroenterologists Want More Evidence on Nonmedical Switching
Published: April 29th 2020 | Updated: September 16th 2024
In Europe, Secondary Patents Can't Stop Biosimilars, Study Says
Published: April 17th 2020 | Updated: September 16th 2024
Patient Awareness of Biosimilars Is Poor in Australia, Study Says
Published: September 12th 2024 | Updated: September 16th 2024
Comparable Disease Activity, Drug Persistence in Patients With JIA Who Switch to Biosimilars
Published: September 7th 2024 | Updated: September 16th 2024
Survey of Clinicians: Lower Cost of Biosimilars Is the Main Driver of Treatment Choice in IBD
Published: March 5th 2024 | Updated: September 16th 2024
FDA Approves First Denosumab Biosimilars